Ocaliva - referral
obeticholic acid
Article 20 procedures
Status: Under evaluation
Last updated:
ReferralHuman
Ocaliva
obeticholic acid
Liver Cirrhosis, Biliary
Date of authorisation:
Revision: 20
Last updated:
MedicineHumanAuthorised
EMEA-001304-PIP02-13-M05 - paediatric investigation plan
Decision type: PM: decision on the application for modification of an agreed PIP
Therapeutic area: Gastroentology-Hepatology
PIP number: P/0041/2021
Route(s) of administration: Oral use
Pharmaceutical form(s):
Coated tablet
Tablet
Age-appropriate oral solid dosage form
Decision date:
Last updated:
Compliance check: ✖
PIPHuman
Doxolipad
doxorubicin
Breast Neoplasms
Ovarian Neoplasms
Date of refusal:
Last updated:
MedicineHumanRefused
EMEA-001304-PIP03-17 - paediatric investigation plan
Decision type: P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
Therapeutic area: Gastroentology-Hepatology
PIP number: P/0104/2018
Route(s) of administration: Oral use
Pharmaceutical form(s):
Age-appropriate oral solid dosage form
Tablet
Decision date:
Last updated:
Compliance check: ✖
PIPHuman